MCID: HDG006
MIFTS: 22

Hodgkin's Paragranuloma

Categories: Blood diseases, Cancer diseases, Immune diseases

Aliases & Classifications for Hodgkin's Paragranuloma

MalaCards integrated aliases for Hodgkin's Paragranuloma:

Name: Hodgkin's Paragranuloma 12 15
Hodgkin Paragranuloma 12
Hodgkin Disease 71

Classifications:



External Ids:

Disease Ontology 12 DOID:8642
UMLS 71 C0019829

Summaries for Hodgkin's Paragranuloma

MalaCards based summary : Hodgkin's Paragranuloma, also known as hodgkin paragranuloma, is related to lymphoma and pneumonia. An important gene associated with Hodgkin's Paragranuloma is UCHL1 (Ubiquitin C-Terminal Hydrolase L1). The drugs Etoposide and Cisplatin have been mentioned in the context of this disorder. Affiliated tissues include t cells, b cells and bone.

Related Diseases for Hodgkin's Paragranuloma

Diseases related to Hodgkin's Paragranuloma via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 4, show less)
# Related Disease Score Top Affiliating Genes
1 lymphoma 10.1
2 pneumonia 10.1
3 orbit lymphoma 10.1
4 orbital lymphoma 10.1

Symptoms & Phenotypes for Hodgkin's Paragranuloma

Drugs & Therapeutics for Hodgkin's Paragranuloma

Drugs for Hodgkin's Paragranuloma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 352, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Etoposide Approved Phase 4 33419-42-0 36462
2
Cisplatin Approved Phase 4 15663-27-1 2767 441203 84093
3
Prednisolone phosphate Approved, Vet_approved Phase 4 302-25-0
4
Methylprednisolone Approved, Vet_approved Phase 4 83-43-2 6741
5
Methylprednisolone hemisuccinate Approved Phase 4 2921-57-5
6 Prednisolone acetate Approved, Vet_approved Phase 4 52-21-1
7
Prednisolone Approved, Vet_approved Phase 4 50-24-8 5755
8
Epirubicin Approved Phase 4 56420-45-2 41867
9
Prednisolone hemisuccinate Experimental Phase 4 2920-86-7
10 Gastrointestinal Agents Phase 4
11 Hormones Phase 4
12 Antiemetics Phase 4
13 Hormone Antagonists Phase 4
14 glucocorticoids Phase 4
15 Anti-Inflammatory Agents Phase 4
16 Etoposide phosphate Phase 4
17 Methylprednisolone Acetate Phase 4
18 Protective Agents Phase 4
19 Neuroprotective Agents Phase 4
20
Moxifloxacin Approved, Investigational Phase 3 354812-41-2, 151096-09-2 152946
21
Panobinostat Approved, Investigational Phase 3 404950-80-7 6918837
22
Ichthammol Approved Phase 3 8029-68-3
23
Cobalt Approved, Experimental Phase 3 7440-48-4 104729
24
Chlorambucil Approved Phase 3 305-03-3 2708
25
Erythromycin Approved, Investigational, Vet_approved Phase 3 114-07-8 12560 441411
26
Aldesleukin Approved Phase 2, Phase 3 85898-30-2, 110942-02-4
27
Daunorubicin Approved Phase 3 20830-81-3 30323
28
Prednisone Approved, Vet_approved Phase 3 53-03-2 5865
29
rituximab Approved Phase 3 174722-31-7 10201696
30
Triamcinolone Approved, Vet_approved Phase 3 124-94-7 31307
31
Oxaliplatin Approved, Investigational Phase 3 61825-94-3 43805 6857599 5310940 9887054
32
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 3 1177-87-3
33
Dexamethasone Approved, Investigational, Vet_approved Phase 3 50-02-2 5743
34
Doxorubicin Approved, Investigational Phase 3 23214-92-8 31703
35
Dacarbazine Approved, Investigational Phase 3 4342-03-4 5351166
36
Vinblastine Approved Phase 3 865-21-4 241903 13342
37
Bleomycin Approved, Investigational Phase 3 11056-06-7 5360373
38
Melphalan Approved Phase 3 148-82-3 460612 4053
39
Gemcitabine Approved Phase 3 95058-81-4 60750
40
Vinorelbine Approved, Investigational Phase 3 71486-22-1 60780 44424639
41
Cyclophosphamide Approved, Investigational Phase 3 50-18-0, 6055-19-2 2907
42
Vincristine Approved, Investigational Phase 3 57-22-7, 2068-78-2 5978
43
Ifosfamide Approved Phase 3 3778-73-2 3690
44
Vindesine Approved, Investigational Phase 3 59917-39-4, 53643-48-4 40839
45
Cortisone Experimental Phase 3 53-06-5 222786
46
Mitoguazone Investigational Phase 3 459-86-9
47 Hematinics Phase 3
48 Epoetin alfa Phase 3 113427-24-0
49 Norgestimate, ethinyl estradiol drug combination Phase 3
50 Fluorodeoxyglucose F18 Phase 3
51 Analgesics, Non-Narcotic Phase 2, Phase 3
52 Interleukin-2 Phase 2, Phase 3
53 Radiopharmaceuticals Phase 3
54 razoxane Phase 3
55 Cardiotonic Agents Phase 3
56 interferons Phase 2, Phase 3
57 Tin Fluorides Phase 3
58 Erythromycin Estolate Phase 3
59 Erythromycin stearate Phase 3
60 penicillins Phase 3
61 Erythromycin Ethylsuccinate Phase 3
62 Interferon-gamma Phase 2, Phase 3
63 Immunoglobulins Phase 3
64 Antibodies Phase 3
65 Antibodies, Monoclonal Phase 3
66 Immunoglobulins, Intravenous Phase 3
67 Podophyllotoxin Phase 3 518-28-5
68 Keratolytic Agents Phase 3
69 Immunoconjugates Phase 3
70 Triamcinolone diacetate Phase 3
71 triamcinolone acetonide Phase 3
72 Triamcinolone hexacetonide Phase 3
73 Myeloma Proteins Phase 3
74 Paraproteins Phase 3
75 Antineoplastic Agents, Hormonal Phase 3
76
Liposomal doxorubicin Phase 3 31703
77 Anti-Bacterial Agents Phase 3
78 Tubulin Modulators Phase 3
79 Antibiotics, Antitubercular Phase 3
80 Antimitotic Agents Phase 3
81 Antirheumatic Agents Phase 3
82
Isophosphamide mustard Phase 3 0
83
Valproic acid Approved, Investigational Phase 2 99-66-1 3121
84
Sargramostim Approved, Investigational Phase 2 83869-56-1, 123774-72-1
85
Goserelin Approved Phase 2 65807-02-5 5311128 47725
86
Mesna Approved, Investigational Phase 1, Phase 2 3375-50-6 598
87
Acetylcysteine Approved, Investigational Phase 2 616-91-1 12035
88
Idelalisib Approved Phase 2 870281-82-6
89
Thioguanine Approved Phase 2 154-42-7 2723601
90
Amifostine Approved, Investigational Phase 2 20537-88-6 2141
91
Vorinostat Approved, Investigational Phase 1, Phase 2 149647-78-9 5311
92
Topotecan Approved, Investigational Phase 2 123948-87-8, 119413-54-6 60700
93
Iodine Approved, Investigational Phase 1, Phase 2 7553-56-2 807
94
Promethazine Approved, Investigational Phase 2 60-87-7 4927
95
Acetaminophen Approved Phase 2 103-90-2 1983
96
Diphenhydramine Approved, Investigational Phase 2 58-73-1, 147-24-0 3100
97
Lomustine Approved, Investigational Phase 2 13010-47-4 3950
98
Methylcobalamin Approved, Investigational Phase 1, Phase 2 13422-55-4
99
Hydroxocobalamin Approved Phase 1, Phase 2 13422-51-0 15589840 11953898
100
Meloxicam Approved, Vet_approved Phase 2 71125-38-7 54677470 5281106
101
Procarbazine Approved, Investigational Phase 1, Phase 2 671-16-9 4915
102
Decitabine Approved, Investigational Phase 2 2353-33-5 451668
103
Mechlorethamine Approved, Investigational Phase 2 51-75-2 4033
104
Romidepsin Approved, Investigational Phase 1, Phase 2 128517-07-7 5352062
105
Sulfamethazine Approved, Investigational, Vet_approved Phase 1, Phase 2 57-68-1 5327
106
nivolumab Approved Phase 1, Phase 2 946414-94-4
107
ofatumumab Approved Phase 2 679818-59-8 6918251
108
Everolimus Approved Phase 1, Phase 2 159351-69-6 70789204 6442177
109
Lenalidomide Approved Phase 1, Phase 2 191732-72-6 216326
110
Pembrolizumab Approved Phase 2 1374853-91-4
111
Angiotensin II Approved, Investigational Phase 2 4474-91-3, 11128-99-7, 68521-88-0 172198
112
Carboplatin Approved Phase 2 41575-94-4 10339178 38904 498142
113
Azacitidine Approved, Investigational Phase 1, Phase 2 320-67-2 9444
114
tannic acid Approved Phase 2 1401-55-4
115
Benzocaine Approved, Investigational Phase 2 94-09-7, 1994-09-7 2337
116
Mannitol Approved, Investigational Phase 2 69-65-8 6251 453
117
Durvalumab Approved, Investigational Phase 1, Phase 2 1428935-60-7
118
Hydrocortisone Approved, Vet_approved Phase 2 50-23-7 5754
119
Hydrocortisone acetate Approved, Vet_approved Phase 2 50-03-3
120
Fluticasone Approved, Experimental Phase 2 90566-53-3 62924
121
Edetic Acid Approved, Vet_approved Phase 1, Phase 2 60-00-4, 62-33-9 6049
122
Pentetic acid Approved Phase 1, Phase 2 67-43-6
123
Cemiplimab Approved, Investigational Phase 2 1801342-60-8
124
Bortezomib Approved, Investigational Phase 2 179324-69-7 387447 93860
125
Lenograstim Approved, Investigational Phase 1, Phase 2 135968-09-1
126
Mycophenolic acid Approved Phase 2 24280-93-1 446541
127
Atezolizumab Approved, Investigational Phase 2 1380723-44-3
128
Thiotepa Approved, Investigational Phase 2 52-24-4 5453
129
Clotrimazole Approved, Vet_approved Phase 2 23593-75-1 2812
130
Vidarabine Approved, Investigational Phase 2 24356-66-9 21704 32326
131
Miconazole Approved, Investigational, Vet_approved Phase 2 22916-47-8 4189
132
Busulfan Approved, Investigational Phase 2 55-98-1 2478